Display options
Share it on
Full text links
HighWire Free PMC Article

Ann Rheum Dis. 1998 May;57(5):281-5. doi: 10.1136/ard.57.5.281.

Serum androgen-anabolic hormones and the risk of rheumatoid arthritis.

Annals of the rheumatic diseases

R Heikkilä, K Aho, M Heliövaara, P Knekt, A Reunanen, A Aromaa, A Leino, T Palosuo

Affiliations

  1. Kanta-Häme Central Hospital, Hämeenlinna, Finland.

PMID: 9741311 PMCID: PMC1752601 DOI: 10.1136/ard.57.5.281
Free PMC Article

Abstract

OBJECTIVE: It has been hypothesised, mainly on the basis of indirect evidence, that low serum concentrations of androgen-anabolic hormones would play a causal part in the aetiology of rheumatoid arthritis (RA).

METHODS: A case-control study was nested with a Finnish cohort of 19,072 adults who had neither arthritis nor a history of it at the baseline examination during 1973-1977. Pre-illness serum specimens for the assay of testosterone and dehydroepiandrosterone sulphate (DHEAS) were available from 116 cases who had developed RA by late 1989. Three controls per each incident case were individually matched for sex, age, and municipality.

RESULTS: The mean testosterone concentration was 1.4 nmol/l in those 84 women who developed RA and 1.4 nmol/l in their controls; the corresponding figures for DHEAS were 5.2 mumol/l and 5.5 mumol/l, respectively. Mean testosterone concentration in the 32 male cases was 26.1 nmol/l and 26.4 nmol/l in their controls; the corresponding figures for DHEAS were 11.2 mumol/l and 10.1 mumol/l, respectively. Analysis by subgroups (rheumatoid factor positive and negative disease, pre-menopausal and postmenopausal women) and by hormone distributions showed no differences.

CONCLUSION: The findings are not in line with the contention that low concentrations of testosterone and DHEAS play a part in the aetiology of RA.

Cited by

References

  1. Am J Epidemiol. 1981 Dec;114(6):804-16 - PubMed
  2. Ann Rheum Dis. 1997 Jun;56(6):351-6 - PubMed
  3. Arthritis Rheum. 1984 Aug;27(8):958-9 - PubMed
  4. Metabolism. 1985 Aug;34(8):731-6 - PubMed
  5. Ann Hum Biol. 1986 Jan-Feb;13(1):63-72 - PubMed
  6. Exp Clin Endocrinol. 1986 Jun;87(1):38-42 - PubMed
  7. Q J Med. 1986 Jul;60(231):671-9 - PubMed
  8. Metabolism. 1986 Dec;35(12):1090-5 - PubMed
  9. J Rheumatol. 1986 Dec;13(6):1019-23 - PubMed
  10. Br J Rheumatol. 1987 Aug;26(4):316-8 - PubMed
  11. Ann Rheum Dis. 1988 Jan;47(1):65-8 - PubMed
  12. Arthritis Rheum. 1988 Aug;31(8):973-8 - PubMed
  13. Arthritis Rheum. 1988 Oct;31(10):1314-7 - PubMed
  14. Br J Rheumatol. 1988 Dec;27(6):440-4 - PubMed
  15. Clin Rheumatol. 1989 Mar;8(1):37-41 - PubMed
  16. Dis Markers. 1989 Jul-Sep;7(3):139-43 - PubMed
  17. Rev Rhum Mal Osteoartic. 1990 Jul-Sep;57(7-8):509-12 - PubMed
  18. J Rheumatol. 1990 Sep;17(9):1125-9 - PubMed
  19. Epidemiol Rev. 1991;13:200-27 - PubMed
  20. J Theor Biol. 1992 Mar 7;155(1):121-8 - PubMed
  21. Circulation. 1992 Nov;86(5):1529-35 - PubMed
  22. J Rheumatol. 1992 Nov;19(11):1663-7 - PubMed
  23. Ann Rheum Dis. 1993 Mar;52(3):211-4 - PubMed
  24. Ann Rheum Dis. 1993 Mar;52(3):244 - PubMed
  25. Ann Rheum Dis. 1993 Jun;52(6):470-4 - PubMed
  26. Epidemiol Rev. 1993;15(1):48-65 - PubMed
  27. Lancet. 1994 Jun 11;343(8911):1479-81 - PubMed
  28. J Rheumatol. 1993 Dec;20(12):2163-4 - PubMed
  29. Br J Rheumatol. 1994 Aug;33(8):697-9 - PubMed
  30. Clin Exp Rheumatol. 1995 Mar-Apr;13(2):227-40 - PubMed
  31. Br J Rheumatol. 1995 Jul;34(7):625-8 - PubMed
  32. Ann Rheum Dis. 1995 Sep;54(9):694-5 - PubMed
  33. Am J Epidemiol. 1996 Jul 1;144(1):1-14 - PubMed
  34. Ann Rheum Dis. 1996 Jun;55(6):404 - PubMed
  35. Atherosclerosis. 1996 Aug 23;125(1):1-13 - PubMed
  36. Arthritis Rheum. 1983 Jul;26(7):935-6 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources